Atropine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Atropine and local guidelines before prescribing.

Antimuscarinic

Mechanism

Competitive muscarinic antagonist.

Uses

Symptomatic bradycardia, organophosphate and cholinergic poisoning, antimuscarinic premedication.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Symptomatic bradycardia500 microg IV every 3–5 min (max 3 mg)May not work in high-grade block; prepare pacing.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Dry mouth, blurred vision, tachycardia, urinary retention, confusion, hot dry skin.

Interactions

Additive antimuscarinic effects with tricyclics and antihistamines.

Contraindications and cautions

Glaucoma (narrow-angle), myasthenia gravis in some settings, obstructive uropathy

Monitoring

ECG, pulse, pupil size

Pregnancy and breastfeeding

Use if needed

Renal and hepatic impairment

No adjustment

Overdose and reversal

Physostigmine rarely; supportive cooling and benzodiazepines

Special advice

May not work in high-grade or infranodal block (prepare pacing); caution in glaucoma and prostatic hypertrophy; in organophosphate poisoning large doses may be needed.